Press release |
Causes of depression in spotlight with £4.7m funding boost
People who have or are at risk of clinical depression could benefit from a new major medical research initiative funded by the Wellcome Trust. The University of Edinburgh has been awarded £4.7 million from the Trust to study depression in new ways, in the hope of developing better treatments.
Experts say that rather than being one disease, clinical depression is a collection of different disorders with one common symptom: low mood.
Over the next five years, the new Strategic Award will enable scientists to study groups of people with known depression risk factors. These include family history of low mood, diseases like heart disease and diabetes, and early-life problems such as low birth weight or childhood psychological trauma. Researchers will then use memory, reasoning and mental speed tests as well as brain imaging to find out whether specific subgroups of patients correspond to specific disorders.
The scientists say that by studying the groups in this way, they hope to be able to identify the causes of depression and that this information will be able to be used to develop diagnostic tests and new therapies. The study, which will also involve researchers from the University of Aberdeen, will use data from Generation Scotland – a large family-based sample of over 21,000 people.
Clinical depression is a chronic worldwide health problem affecting millions of people, including around 13 per cent of the UK population. Although it is a recurrent problem for many people, little is known about what makes people vulnerable or resilient to the condition.
Depression first affects many in adolescence or in early adulthood and it is a common cause of suicide.
Lead researcher Andrew McIntosh, Professor of Biological Psychiatry at the University of Edinburgh, said: “For many people, the symptom of low mood is the most understandable of reactions to loss or stress, yet we remain ignorant of its causes and mechanisms. This means that progress in discovering new and more effective treatments is slow. This Wellcome Trust grant will enable us to make significant progress with this common and disabling condition.”
Ian Deary, Director of the University of Edinburgh’s Centre for Cognitive Ageing and Cognitive Epidemiology, said: “It is good to see this support for our broadening-out of the research on depression, paying closer attention to the thinking skills that alter when people are depressed, and to the brain changes that occur. Our hope is that we will be able to study enough of these factors in a large-enough group of people to start to understand depression better.”
The study – known as Stratifying Resilience and Depression Longitudinally (STRADL) – involves researchers from the University of Edinburgh’s Division of Psychiatry, Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE) and Institute for Genetics and Molecular Medicine (IGMM), and brain imaging facilities in Edinburgh and at the University of Aberdeen.